High circulating levels of 25-hydroxyvitamin D₃ in renal stone formers with hyperabsorptive hypercalciuria

References

• Shen F H, Baylink D J, Nielsen R I, Sherrard D J, Ivey J L, Haussler M R. Increased serum 1,25‐dihydroxyvitamin D3 in idiopathic hypercalciuria. J Lab Clin Med 1977; 90: 955–62
   PubMed Web of Science ®Google Scholar
• Kaplan R A, Haussler M R, Deftos L J, Bone H, Pak C YC. The role of 1,25‐dihydroxyvitamin D3 in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest 1977; 59: 756–60
   PubMed Web of Science ®Google Scholar
• Coe F L, Favus M J, Crockett T, Strauss A L, Parks J H, Porat A, Gantt C L, Sherwood L M. Effects of low‐calcium diet on urinary excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med 1982; 72: 25–32
   PubMed Web of Science ®Google Scholar
• Van Den Berg C J, Kumar R, Wilson D M, Heath H, Smith L H. Ortophosphate therapy decreases urinary calcium excretion and serum 1,25‐dihydroxyvitamin D3 concentrations in idiopathic hypercalciuria. J Clin Endocrinol Metab 1980; 51: 998–1001
   PubMed Web of Science ®Google Scholar
• Broadus A E, Insogna K L, Lang R, Mallette L E, Oren D A, Gertner J M, Kliger A S, Ellison A F. A consideration of the hormonal basis and phosphate leak hypothesis of absorptive hypercalciuria. J Clin Endocrinol Metab 1984; 58: 161–9
   PubMed Web of Science ®Google Scholar
• Brodaus A E, Insogna K L, Lang R, Ellison A F, Dreyer B E. Evidence for disordered control of 1,25‐dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med 1984; 311: 73–80
   PubMed Web of Science ®Google Scholar
• Jongen M JM. The role of vitamin D in the pathogenesis of urinary calcium‐stone disease. Thesis, Juuriaans, Amsterdam 1983
   Google Scholar
• DeLuca H F. Vitamin D, metabolism and function. Monographs on Endocrinology. Springer Verlag, New York 1979; 43
   Google Scholar
• Caldas A E, Gray R W, Lemann J. The simultaneous measurement of vitamin D metabolites in plasma: studies in healthy adults and in patients with calcium nephrolithiasis. J Lab Clin Med 1978; 91: 840–9
   PubMed Web of Science ®Google Scholar
• Schmidt‐Gayk H, Tschope W, Schellenberg B, Schlierf G, Walch S. Vitamin D‐Stoffwechsel bei Urolithiasis: neuere Befunde und Untersuchungs‐metoden. Therapiewoche 1979; 29: 2137–41
   Google Scholar
• Berlin T, Björkhem I, Collste L, Holmberg I, Wijkström H. Relation between hypercalciuria and vitamin D3‐status in patients with urolithiasis. Scand J Urol Nephrol 1982; 16: 269–73
   PubMed Web of Science ®Google Scholar
• Elomaa I, Karonen S L, Kairento A L, Pelkonen R. Seasonal variation of urinary calcium and oxalate excretion, serum 25(OH)D3 and albumin level in relation to renal stone formation. Scand J Urol Nephrol 1982; 16: 155–61
   PubMed Web of Science ®Google Scholar
• Parry E S, Lister I S. Sunlight and hypercalciuria. Lancet 1975; 1: 1063–5
   PubMed Web of Science ®Google Scholar
• Robertson W G, Gallagher J C, Marshall D H, Peacock M, Nordin B E. Seasonal variations in urinary excretion of calcium. Br Med J 1974; 4: 436–7
   PubMed Web of Science ®Google Scholar
• McLaughlin M, Fairney A, Lester E, Ragatt P R, Brown D J, Wills M R. Seasonal variations in serum 25‐hydroxycholecalciferol in healthy people. Lancet 1974; 1: 536–8
   PubMed Web of Science ®Google Scholar
• Björkhem I, Holmberg I. Mass fragmentography of 25‐hydroxyvitamin D3. Quantitative Mass Spectrometry. Life Sci, A P de Leenheer, R R Roncucci, C van Peteghem. Elsevier, Amsterdam 1978; II: 167–174
   Google Scholar
• Björkhem I, Holmberg I. Mass fragmentographic assay of 25‐hydroxyvitamin D3. Methods in Enzymology 1980; 67: 385–93
   PubMedGoogle Scholar
• Reinhard T A, Horst R L, Orf J W, Hollis B W. A microassay for 1,25‐dihydroxyvitamin D3 not requiring HPLC. Application to clinical studies. J Clin Endocrinol Metab 1984; 58: 91–8
   PubMed Web of Science ®Google Scholar
• Walton R J, Bijvoet O LM. Nomogram for derivation of renal threshold phosphate concentration. Lancet 1975; 2: 309–10
   PubMed Web of Science ®Google Scholar
• Pak C YC, Kaplan R, Bone H, Townsend J, Waters O. A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N Engl J Med 1975; 292: 497–500
   PubMed Web of Science ®Google Scholar
• Holmberg I, Kristiansen T, Sturen M. Determination of 25‐hydroxyvitamin D3 in serum by high performance liquid chromatography and isotope dilution‐mass spectrometry. Scand J Clin Lab Invest 1984; 44: 275–82
   PubMed Web of Science ®Google Scholar
• Haddad J G, Hahn T J. Natural and synthetic sources of circulating 25‐hydroxyvitamin D in man. Nature 1973; 244: 515–7
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Okano T, Shida S, Okada K, Suginohara T, Nakao H, Kuroda E, Kodama S, Matsuo T. Variation of 25‐hydroxyvitamin D3 and 25‐hydroxyvitamin D2 levels in human plasma obtained from 758 Japanese healthy subjects. J Nutr Sci Vitaminol 1983; 29: 271–81
   PubMed Web of Science ®Google Scholar
• Puschett J B, Beck W S, Jelonek A. Parathyroid hormone and 25‐hydroxyvitamin D3: synergistic and antagonistic effects on renal phosphate transport. Science 1975; 190: 473–5
   PubMed Web of Science ®Google Scholar
• Birge J S, Haddad J G. 25‐hydroxycholecalciferol stimulation of muscle metabolism. J Clin Invest 1975; 56: 1100–7
   PubMed Web of Science ®Google Scholar
• Fraser D R. Biochemical and clinical aspects of vitamin D function. Br Med Bull 1981; 37: 37–42
   PubMed Web of Science ®Google Scholar
• Bell N H, Shaw S, Turner R T. Evidence that 1,25‐dihydroxyvitamin D3 inhibits the hepatic production of 25‐hydroxyvitamin D in man. J Clin Invest 1984; 74: 1540–4
   PubMed Web of Science ®Google Scholar